KBC GROUP NV – Vertex Pharmaceuticals Incorporated Transaction History
KBC GROUP NV portfolio value:
$73.29M
portfolio value
KBC GROUP NV quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.29% | -35.47K shares | -8.03M | $289.54 | 253.12K |
| Q2 2022 | share | Increase | +3.65% | 10.16K shares | 8.66M | $281.79 | 288.60K |
| Q1 2022 | share | Decrease | -52.42% | -306.81K shares | -55.85M | $260.97 | 278.43K |
| Q4 2021 | share | Increase | +108.90% | 305.09K shares | 77.70M | $222.45 | 585.25K |
| Q3 2021 | share | Decrease | -5.40% | -15.98K shares | -8.89M | $181.39 | 280.16K |
| Q2 2021 | share | Increase | +17.05% | 43.13K shares | 5.34M | $201.63 | 296.14K |
| Q1 2021 | share | Increase | +3.44% | 8.41K shares | -3.43M | $214.89 | 253.01K |
| Q4 2020 | share | Increase | +65.02% | 96.37K shares | 17.47M | $236.34 | 244.59K |
| Q3 2020 | share | Increase | +21.24% | 25.96K shares | 4.84M | $272.12 | 148.21K |
| Q2 2020 | share | Increase | +23.19% | 23.00K shares | 11.87M | $290.31 | 122.24K |
| Q1 2020 | share | Decrease | -13.53% | -15.52K shares | -1.51M | $237.95 | 99.24K |
| Q4 2019 | share | Decrease | -0.42% | -481 shares | 5.60M | $218.95 | 114.76K |
| Q3 2019 | share | Increase | +21.42% | 20.33K shares | 2.11M | $169.42 | 115.25K |
| Q2 2019 | share | Increase | +25.06% | 19.02K shares | 3.44M | $183.38 | 94.91K |
| Q1 2019 | share | Increase | +20.73% | 13.03K shares | 3.54M | $183.95 | 75.89K |
| Q4 2018 | share | Increase | +80.67% | 28.06K shares | 3.71M | $165.71 | 62.86K |
| Q3 2018 | share | Increase | +42.74% | 10.41K shares | 2.56M | $192.74 | 34.79K |
| Q2 2018 | share | Increase | +24.74% | 4.83K shares | 958K | $169.96 | 24.37K |
| Q1 2018 | share | Decrease | -14.01% | -3.18K shares | -221K | $162.98 | 19.54K |
| Q4 2017 | share | Decrease | -22.05% | -6.42K shares | -1.02M | $149.86 | 22.72K |
| Q3 2017 | share | Increase | +10.49% | 2.76K shares | 1.03M | $152.04 | 29.15K |
| Q2 2017 | share | Decrease | -3.57% | -978 shares | 409K | $128.87 | 26.38K |
| Q1 2017 | share | Decrease | -53.17% | -31.07K shares | -1.31M | $109.35 | 27.36K |
| Q4 2016 | share | Decrease | -23.08% | -17.53K shares | -2.32M | $73.67 | 58.43K |
| Q3 2016 | share | Decrease | -24.97% | -25.28K shares | -2.08M | $87.21 | 75.97K |
| Q2 2016 | share | Increase | +6.36% | 6.05K shares | 1.14M | $86.02 | 101.26K |
| Q1 2016 | share | Increase | +123.37% | 52.58K shares | 2.20M | $79.49 | 95.20K |